From GlobeNewswire:

QIAGEN N.V. is returning up to approximately $300 million to shareholders through a synthetic share repurchase combining direct capital repayment with a reverse stock split. This plan utilizes the mandate given at the Annual General Meeting in June 2023. This move is meant to streamline shareholder pay-out, enhance earnings per share, and create value for shareholders and other stakeholders. The synthetic share repurchase will be effective on January 29, 2024, and will be settled in line with market convention in the subsequent days. After the repurchase, the company plans to review and explore other options to create greater value such as targeted M&A opportunities.



Read more: QIAGEN announces plans to return approximately $300 million